EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieKlinische Studie (Phase III)Open Access

Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial

M Palmer, M M van der Zalm, H S Schaaf, P Goussard, J Morrison, J A Seddon, S Hissar, D Baskaran, A Kinikar, P Raichur, E Wobudeya, C Chabala und 5 weitere

The International Journal of Tuberculosis and Lung Disease · 01.11.2024 · 28 (11) · 547-553

DOI: 10.5588/ijtld.24.0076 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The International Journal of Tuberculosis and Lung Disease, erschienen am 01.11.2024. Verfasst von M Palmer und 16 weiteren Autor:innen. Beteiligte Einrichtung: Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa. Hauptthemen laut MEDLINE: Radiography, Thoracic, Tuberculosis, Pulmonary, Antitubercular Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, FIC NIH HHS, Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION

SHINE (Shorter Treatment for Minimal Tuberculosis in Children) was the first Phase 3 paediatric TB treatment-shortening trial. Robust chest X-ray (CXR) classification methods were integral to excluding severe disease for trial eligibility and to retrospectively adjudicating TB status at baseline. We describe and critically evaluate the CXR classification approaches and processes used in the SHINE trial.





METHODS

Children with non-severe TB were randomised to 4- vs 6-months anti-TB treatment. Radiologically non-severe TB was defined on CXR. CXRs were systematically interpreted by on-site clinicians prospectively for eligibility determination and retrospectively by experts to inform adjudication of baseline TB status and disease severity.





RESULTS

A screening CXR was successfully obtained from all 1,204 enrolled children; 1,134 CXRs from children with intra-thoracic TB were reviewed by expert readers. Compared with the expert panel, enrolling clinicians classified more CXRs as abnormal and ‘typical TB’ and all as radiologically non-severe. The expert panel retrospectively classified 71/1,134 (6%) CXRs as severe. Of these, 4 (5.6%) had unfavourable outcomes compared with 34 (3.0%) in the trial overall.





DISCUSSION

Using CXRs to classify radiological disease severity and inform eligibility decisions in real-time by local enrolling clinicians was feasible and safe in this large paediatric TB trial. Retrospective central expert CXR review was successful. Refinement of the CXR methods for the classification of both disease severity and TB status could support standardised implementation in routine care and research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Radiography, ThoracicTuberculosis, PulmonaryAntitubercular AgentsHumansChildChild, PreschoolSeverity of Illness IndexRetrospective StudiesInfantFemaleMaleProspective StudiesTime Factors

Substanzen

Antitubercular Agents

Autor:innen und Institutionen

  • Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
  • Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
  • Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa;, Department of Infectious Disease, Imperial College London, London, United Kingdom.
  • National Institute for Research in Tuberculosis, Chennai, India.
  • B.J. Government Medical College, Pune, India.
  • Makerere University-Johns Hopkins University Research Collaboration, Kampala, Uganda.

Förderung

  • Wellcome Trust
  • FIC NIH HHS
  • Medical Research Council

Zitieren

APA

Palmer, M., van der Zalm, M. M., Schaaf, H. S., Goussard, P., Morrison, J., Seddon, J. A., Hissar, S., Baskaran, D., Kinikar, A., Raichur, P., Wobudeya, E., Chabala, C., Lebeau, K., Crook, A. M., Turkova, A., Gibb, D., & Hesseling, A. C. (2024). Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial. The International Journal of Tuberculosis and Lung Disease, 28(11), 547-553. https://doi.org/10.5588/ijtld.24.0076

Vancouver

Palmer M, van der Zalm MM, Schaaf HS, Goussard P, Morrison J, Seddon JA, et al. Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial. The International Journal of Tuberculosis and Lung Disease. 2024;28(11):547-553. doi:10.5588/ijtld.24.0076

BibTeX
@article{Palmer2024,
  author = {Palmer, M and van der Zalm, M M and Schaaf, H S and Goussard, P and Morrison, J and Seddon, J A and Hissar, S and Baskaran, D and Kinikar, A and Raichur, P and Wobudeya, E and Chabala, C and Lebeau, K and Crook, A M and Turkova, A and Gibb, D and Hesseling, A C},
  title = {Approaches and processes for paediatric chest X-ray classification used in the SHINE TB treatment-shortening trial},
  journal = {The International Journal of Tuberculosis and Lung Disease},
  year = {2024},
  volume = {28},
  number = {11},
  pages = {547--553},
  doi = {10.5588/ijtld.24.0076}
}
Kostenlos starten →